163 related articles for article (PubMed ID: 29455539)
1. Immunological evaluation of chitosan nanoparticles loaded with tetanus toxoid.
Ghalavand M; Saadati M; Ahmadi A; Abbasi E; Salimian J
Bratisl Lek Listy; 2018; 119(2):71-74. PubMed ID: 29455539
[TBL] [Abstract][Full Text] [Related]
2. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
Pirouzmand H; Khameneh B; Tafaghodi M
Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
[TBL] [Abstract][Full Text] [Related]
3. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
4. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment.
Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511
[TBL] [Abstract][Full Text] [Related]
5. Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses.
Kaur A; Jyoti K; Rai S; Sidhu R; Pandey RS; Jain UK; Katyal A; Madan J
J Microencapsul; 2016 May; 33(3):263-73. PubMed ID: 27056086
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory effect of tetanus toxoid loaded chitosan nanoparticles following microneedles assisted immunization.
Siddhapura K; Harde H; Jain S
Nanomedicine; 2016 Jan; 12(1):213-22. PubMed ID: 26554391
[TBL] [Abstract][Full Text] [Related]
7. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
Aggerbeck H; Heron I
Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles.
Sudheesh MS; Vyas SP; Kohli DV
Drug Deliv; 2011 Jul; 18(5):320-30. PubMed ID: 21351824
[TBL] [Abstract][Full Text] [Related]
9. Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration.
Harde H; Siddhapura K; Agrawal AK; Jain S
Int J Pharm; 2015 Jun; 487(1-2):292-304. PubMed ID: 25895719
[TBL] [Abstract][Full Text] [Related]
10. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies.
Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
Int J Pharm; 2013 Jan; 441(1-2):636-42. PubMed ID: 23117021
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system.
Bansal V; Kumar M; Bhardwaj A; Brahmne HG; Singh H
Vaccine; 2015 Oct; 33(42):5623-5632. PubMed ID: 26343498
[TBL] [Abstract][Full Text] [Related]
12. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.
Westerink MA; Smithson SL; Srivastava N; Blonder J; Coeshott C; Rosenthal GJ
Vaccine; 2001 Dec; 20(5-6):711-23. PubMed ID: 11738734
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
[TBL] [Abstract][Full Text] [Related]
14. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
15. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response.
Stojanović M; Zivković I; Inić-Kanada A; Petrusić V; Mićić M; Dimitrijević L
Microbiol Immunol; 2009 Feb; 53(2):89-100. PubMed ID: 19291092
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses.
Fathi Najafi M; Rahman Mashhadi M; Hemmaty M
Arch Razi Inst; 2020 Oct; 75(3):385-395. PubMed ID: 33025779
[TBL] [Abstract][Full Text] [Related]
17. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
[TBL] [Abstract][Full Text] [Related]
19. Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis.
Amini Y; Moradi B; Fasihi-Ramandi M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1331-1335. PubMed ID: 27647321
[TBL] [Abstract][Full Text] [Related]
20. Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant.
Arora R; Haile CN; Kosten TA; Wu Y; Ramakrishnan M; Hawkins LD; Orson FM; Kosten TR
Am J Addict; 2019 Feb; 28(2):119-126. PubMed ID: 30701618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
